Eardrops licensed to treat otitis externa and localised superficial skin infections
Each ml contains:
Active substances:
Miconazole nitrate 23.0mg (equivalent to 19.98mg miconazole)
Prednisolone acetate 5.0mg (equivalent to 4.48mg prednisolone)
Polymyxin B sulfate 0.5293mg (equivalent to 5500 IU polymyxin B sulfate)
White suspension.
For the treatment of otitis externa and small localised superficial skin infections in dogs and cats caused by infections with the following miconazole and polymyxin B sensitive bacteria and fungi:
• Gram-positive bacteria
–Staphylococcus spp.
– Streptococcus spp.
• Gram-negative bacteria
–Pseudomonas spp.
–Escherichia coli
• Yeasts and fungi
–Malassezia pachydermatis
–Candida spp.
–Microsporum spp.
–Trichophyton spp.
Treatment of Otodectes cynotis infestations where there is concurrent infection with miconazole and polymyxin B sensitive pathogens.
Do not use:
- in cases of hypersensitivity to the active substances of the veterinary medicinal product, as well as to other corticosteroids, to other azole antifungal agents, or to the excipients
- in animals with perforated ear drums
- in animals, where resistance of causative agents to polymyxin B and/or miconazole is known
- on the mammary glands of lactating bitches and queens
Use of this veterinary medicinal product may very rarely be associated with the occurrence of deafness (especially in older dogs), in this case treatment should be discontinued. Prolonged and extensive use of topical corticosteroid preparations is known to trigger local and systemic effects, including suppression of adrenal function, thinning of the epidermis and delayed healing. If you notice any serious effects or other effects not mentioned in this package leaflet, please inform your veterinary surgeon.
Dogs and cats.
For auricular and cutaneous use. Shake well before use. At the beginning of treatment, hair surrounding or covering the lesions must be clipped; this should be repeated during treatment if necessary.
Clean the external ear canal and auricle and place 5 drops of the veterinary medicinal product into the external auditory canal twice a day. Massage the ear and the auditory canal thoroughly to ensure proper distribution of the active substances, but gently enough to avoid causing pain to the animal. Treatment should be continued without interruption until a few days after complete disappearance of the clinical symptoms, at least for 7 - 10 days up to 14 days.
Where concurrent ear mite (Otodectes cynotis) infestation is present, consideration should be given to treating both ears even if infestation is only apparent in one ear. Instill 5 drops twice daily for 14 days.
Apply a few drops of the veterinary medicinal product to the skin lesions to be treated twice a day and rub well. Treatment should be continued without interruption until a few days after complete disappearance of the clinical symptoms, up to 14 days. In some persistent cases (ear or skin infections), treatment may need to be continued for 2 to 3 weeks. However, if prolonged treatment is necessary, the veterinarian should be contacted for a repeat clinical examination.
Shake well before use. See Special warnings section.
Not applicable.
Keep out of the sight and reach of children. Do not store above 30 ÌŠC. After first opening do not store above 25 ÌŠC. Do not use this veterinary medicinal product after the expiry date which is stated on the carton and bottle label after “EXP”.
Shelf-life after first opening the container: 3 months.
When the container is broached (opened) for the first time, using the in-use shelf-life which is specified, the date on which any product remaining should be discarded should be worked out. This discard date should be written in the space provided.
Use of the product should be based on microbiological sampling and susceptibility testing of the bacteria and/or fungi isolated from the animal. If this is not possible, therapy should be based upon local (regional) epidemiological information about susceptibility of the causative pathogens. Systemic corticosteroid effects are possible, especially when the product is used under an occlusive dressing, on extensive skin lesions, with increased skin blood flow, or if the product is ingested by licking. Oral ingestion of the product by treated animals or animals having contact with treated animals should be avoided.
People with known hypersensitivity to prednisolone, polymyxin B or miconazole should avoid contact with the veterinary medicinal product. Avoid contact with skin or eyes. In case of accidental spillage, skin or eyes should be rinsed immediately with plenty of water. Always wear single use disposable gloves when applying the veterinary medicinal product to animals. Wash hands after use.
In case of accidental ingestion, seek medical advice immediately and show the leaflet or the label to the physician.
The safety of the product has not been assessed during pregnancy and lactation. Use only accordingly to the benefit/risk assessment by the veterinarian. Special precautions for the disposal of unused product or waste materials, if any. Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.
June 2016
Pack size: 1 x 20ml
For any information about this veterinary medicinal product, please contact the local representative of the marketing authorisation holder. To be supplied only on veterinary prescription.
For animal treatment only.
Richter Pharma AG, Feldgasse 19, 4600 Wels, Austria
Richter Pharma AG, Durisolstrasse 14, 4600 Wels, Austria
Animalcare Ltd, 10 Great North Way, York YO26 6RB, UK
All prices include VAT where applicable.
SUMMARY OF PRODUCT CHARACTERISTICS
NAME OF THE VETERINARY MEDICINAL PRODUCT
Mitex ear drops and cutaneous suspension for dogs and cats (AT, DE, EE, EL, ES, FR, HR, IT, LT, LV, PT, SI)
Saniotic vet. ear drops and cutaneous suspension for dogs and cats (DK, FI, IS, NO, SE
Aurimic ear drops and cutaneous suspension for dogs and cats (BE, BG, IE, NL, RO, UK
Orilan ear drops and cutaneous suspension for dogs and cats (CZ, HU, PL, SK)
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
Active substances: Miconazole nitrate 23.0 mg (equivalent to 19.98 mg miconazole) Prednisolone acetate 5.0 mg (equivalent to 4.48 mg prednisolone) Polymyxin B sulfate 0.5293 mg (equivalent to 5500 IU polymyxin B sulfate)
Excipients: For the full list of excipients, see section 6.1
PHARMACEUTICAL FORM
Ear drops and cutaneous suspension. White suspension.
CLINICAL PARTICULARS
Target species
Dogs and cats.
Indications for use, specifying the target species
For the treatment of otitis externa and small localised superficial skin infections in dogs and cats caused by infections with the following miconazole and polymyxin B sensitive bacteria and fungi:
Gram-positive bacteria Staphylococcus spp. Streptococcus spp. Gram-negative bacteria Pseudomonas spp. Escherichia coli Yeasts and fungi Malassezia pachydermatis Candida spp. Microsporum spp. Trichophyton spp.
Treatment of Otodectes cynotis infestations where there is concurrent infection with miconazole and polymyxin B sensitive pathogens.
Contraindications
Do not use: in case of hypersensitivity to the active substances of the veterinary medicinal product, as well as to other corticosteroids, to other azole antifungal agents, or to the excipients in animals with perforated ear drums in animals, where resistance of causative agents to polymyxin B and/or miconazole is known on the mammary glands of lactating bitches and queens
Special warnings for each target species
Bacterial and fungal otitis is often secondary in nature. The underlying cause should be identified and treated.
Special precautions for use
Special precautions for use in animals Use of the product should be based on microbiological sampling and susceptibility testing of the bacteria and/or fungi isolated from the animal. If this is not possible, therapy should be based upon local (regional) epidemiological information about susceptibility of the target pathogens.
Systemic corticosteroid effects are possible, especially when the product is used under an occlusive dressing, on extensive skin lesions, with increased skin blood flow, or if the product is ingested by licking.
Oral ingestion of the product by treated animals or animals having contact with treated animals should be avoided.
Special precautions to be taken by the person administering the veterinary medicinal product to animals People with known hypersensitivity to prednisolone, polymyxin B or miconazole should avoid contact with the veterinary medicinal product.
Avoid contact with skin or eyes. In case of accidental spillage, skin or eyes should be rinsed immediately with plenty of water. Always wear single use disposable gloves when applying the veterinary medicinal product to animals. Wash hands after use. In case of accidental ingestion, seek medical advice immediately and show the leaflet or the label to the physician.
Adverse reactions (frequency and seriousness)
Use of this veterinary medicinal product may very rarely be associated with the occurrence of deafness (especially in older dogs), in this case treatment should be discontinued. Prolonged and extensive use of topical corticosteroid preparations is known to trigger local and systemic effects, including suppression of adrenal function, thinning of the epidermis and delayed healing.
Use during pregnancy and lactation
The safety of the product has not been assessed during pregnancy and lactation. Absorption of miconazole, polymyxin B and prednisolone through the skin being low, no teratogenic/ embryotoxic/foetotoxic and maternotoxic effects are expected in dogs and cats. Oral ingestion of the active substances by treated animals when grooming can possibly occur and appearance of the active ingredients in blood and milk can be expected. Use only accordingly to the benefit/risk assessment by the veterinarian.
Interaction with other medicinal products and other forms of interaction
No data available.
Amounts to be administered and administration route
For auricular and cutaneous use. Shake well before use.
At the beginning of treatment, hair surrounding or covering the lesions must be clipped; this should be repeated during treatment if necessary.
Infections of the external auditory canal (otitis externa): Clean the external ear canal and auricle and place 5 drops of the veterinary medicinal product into the external auditory canal twice a day. Massage the ear and the auditory canal thoroughly to ensure proper distribution of the active substances, but gently enough to avoid causing pain to the animal. Treatment should be continued without interruption until a few days after complete disappearance of the clinical symptoms, at least for 7 - 10 days up to 14 days. Where concurrent ear mite (Otodectes cynotis) infestation is present, consideration should be given to treating both ears even if infestation is only apparent in one ear. Instill 5 drops twice daily for 14 days.
Skin infections (small localised superficial): Apply a few drops of the veterinary medicinal product to the skin lesions to be treated twice a day and rub well. Treatment should be continued without interruption until a few days after complete disappearance of the clinical symptoms, up to 14 days.
In some persistent cases (ear or skin infections), treatment may need to be continued for 2 to 3 weeks. In cases where prolonged treatment is necessary repeated clinical examinations including a re- assessment of the diagnosis are required.
Overdose (symptoms, emergency procedures, antidotes), if necessary
No other symptoms than those mentioned in section 4.6 are expected.
Withdrawal period(s)
Not applicable.
PHARMACOLOGICAL PROPERTIES
Pharmacotherapeutic group: Otologicals, corticosteroids and anti-infectives in combination ATCvet code: QS02CA01
Pharmacodynamic properties Miconazole belongs to the group of N-substituted imidazole derivatives and inhibits ergosterol de novo synthesis. Ergosterol is an essential membrane lipid and must be synthesised by fungi. Ergosterol deficiency impedes numerous membrane functions, eventually leading to the cell’s death. The spectrum of activities covers nearly all fungi and yeasts of relevance to veterinary medicine as well as Gram-positive bacteria. Practically no development of resistance has been reported. Miconazole has a fungistatic mode of action, but high concentrations are also observed to produce fungicidal effects.
Polymyxin B belongs to the polypeptide antibiotics which are isolated from bacteria. It is only active against Gram-negative bacteria. The development of resistance is chromosomal in nature and the development of resistant Gram-negative pathogens is a relatively rare event. However, all Proteus species share a natural resistance to polymyxin B. Polymyxin B binds to phospholipids in the cytoplasmic membrane to disturb membrane permeability. This results in autolysis of the bacteria, thus achieving bactericidal activity.
Prednisolone is a synthetic corticosteroid and is used for its anti-inflammatory, anti-pruritic, anti- exudative and anti-proliferative effects. The anti-inflammatory activity of prednisolone acetate results from reduction of the permeability of capillaries, improved blood flow and inhibition of fibroblast action.
The exact mechanism of the acaricidal effect is unclear. It is assumed that the mites are suffocated or immobilised by the oily excipients.
Pharmacokinetic particulars
Following topical application of polymyxin B, there is virtually no absorption of the compound through intact skin and mucous membranes, but significant absorption via wounds.
After topical application of miconazole, there is virtually no absorption of the compound through intact skin or mucous membranes.
When applied topically to intact skin, prednisolone is subject to limited and delayed absorption. Greater absorption of prednisolone should be expected in cases of compromised skin barrier function (e.g. skin lesions).
PHARMACEUTICAL PARTICULARS
List of excipients
Silica, colloidal anhydrous Paraffin liquid
Incompatibilities
None known.
Shelf life
Shelf-life of the veterinary medicinal product as packaged for sale: 2 years Shelf-life after first opening the immediate packaging: 3 months
Special precautions for storage
Do not store above 30°C. After first opening do not store above 25°C. Nature and composition of immediate packaging
Dropper container of white, opaque LDPE with white, opaque HDPE screw cap. Pack size: 1 x 20 ml
Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.
MARKETING AUTHORISATION HOLDER
Richter Pharma AG Feldgasse 19 4600 Wels Austria
MARKETING AUTHORISATION NUMBER
Vm 22080/4006
DATE OF FIRST AUTHORISATION
05 March 2015
DATE OF REVISION OF THE TEXT
December 2017
Approved: 05/12/2017
Under almost all products on our website is an Estimated dispatch time, check this for a delivery prediction specific to the item you are looking to purchase. These badges are updated live based on the stock levels we have and also those of our suppliers - so are usually very accurate, but cannot be guaranteed. In more general terms, we aim to dispatch all orders within 1 working day of receiving payment (and a prescription if required). If we cannot do so within 3 working days we will contact you by email.
For UK delivery, we charge the following:
| Order Total | Weight | Delivery |
| £0-£28.99 | Under 2kg | £2.99 |
| 2kg+ | £4.99 | |
| £29-£38.99 | Under 2kg | Free |
| 2kg+ | £4.99 | |
| £39+ | Under 2kg | Free |
| 2kg+ | Free |
Prices quoted are for delivery to all parts of mainland UK except certain Scottish postcodes (where the price is higher for items sent by courier. Delivery of food abroad (including Channel Islands, N. Ireland and other islands around the UK) is charged at a higher price and free delivery is not available. Temperature controlled products, such as Insulin, are also not always subject to the standard and/or free delivery options.
For full information on our delivery charges, including prices on heavy deliveries to Scotland and abroad, see our delivery information page.
We can deliver most items to all around the world, but prices do vary. The majority of light weight orders (less than 1.5kg) can be delivered for a flat rate of £10. For an accurate estimate of the delivery charge, please put the items you require in your basket and use the "Estimate Delivery" system on the shopping basket page (you only need to enter your country and postal/zip code) for a quick quote. For deliveries to the USA you may need to go to the checkout page and enter your full address to get a quote (as some services need your state in order to quote too). For more information on international deliveries, please see our delivery information page.
Due to restrictions aerosols can't be sent by Royal Mail. We appreciate your understanding.
Some products, such as insulin and frozen food, need to be delivered in insulated packaging to prevent them from getting too warm (or too cold) during transit from us to you. Purchasing any of these items in your order will result in a £1.99 charge being added to the total to cover the high cost of the insulated packaging materials. You only pay the £1.99 once per order, regardless of how many temperature controlled items you purchase in that order.
Please call us as soon as possible if you need to amend or cancel an order on 01582 842096. If your order has been processed for dispatch we will be unable to cancel or amend the order. You will however be able to return your product for a full refund*.
To return an item, you must contact us by phone or email to arrange this BEFORE posting any product back to us. We will explain the process at this stage for you.
*For full details on returns, see our terms and conditions page.
There are currently no questions for Aurimic - be the first to ask one!
